Anti-Cancer Drugs is an international medical journal, which aims to promote and encourage research on anti-cancer agents. It was first published in 1990 and it includes reports on clinical and experimental research results, from conventional cytotoxic chemotherapy to hormonal or biological response modalities.
Tagrix, Osimert, Osicent, olanib, Osimert, Caboxen, Ibruxen, Avalet, Rutinib cream, Panatinix, Elbonix, Crizocent, Sotoxen, lorbexen

Our Products :

1. Tagrix
2. Osimert
3. Osicent
4 olanib
5. Osimert
6. Caboxen
7. Ibruxen
8. Avalet
9. Rutinib cream
10. Ponatinix
11. Elbonix
12. Crizocent
13. Sotoxen
14. Lorbrexen

Tagrix 80mg (Osimertinib), Osimert 80mg (Osimertinib), Osicent 80mg (Osimertinib), Olanib-50/150 mg (Olaparib), Osimert 80mg (Osimertinib), Caboxen 20mg (Cabozantinib), Ibruxen Capsule 140mg (Ibrutinib 140mg), Avalet 20mg (Avatrombopag), Rutinib Cream 30 (Ruxolitinib), Ponatinix 45mg (Ponatinib), Elbonix 50mg & Elbonix 25mg (Eltrombopag ), Crizocent 250 Mg (Crizotinib), Sotoxen 120mg (Sotorasib), Lorbrexen 100 Mg (Lorlatinib) provider in the world.